BDX Q4 2020 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q4 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.8B+4.4% YoY

Gross Profit

$2.2B46.1% margin

Operating Income

$255M5.3% margin

Net Income

$128M2.7% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+24.1%

Cash Flow

Operating Cash Flow

$1.5B

Free Cash Flow

$1.3B

Stock-Based Comp.

$51M

Balance Sheet

Total Assets

$54.0B

Total Liabilities

$30.2B

Stockholders' Equity

$23.8B

Cash & Equivalents

$2.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.8B	$4.6B	+4.4%
Gross Profit	$2.2B	$2.3B	-2.6%
Operating Income	$255M	$111M	+129.7%
Net Income	$128M	$162M	-21.0%

Revenue Segments

Medical

$2.3B48%

Life Sciences

$1.5B31%

Interventional

$978M20%

Geographic Segments

UNITED STATES

$2.8B58%

Non-US

$2.0B42%